Jane Street’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,900
Closed -$2.64M 11911
2025
Q4
$2.64M Buy
24,900
+17,500
+236% +$2.03M ﹤0.01% 4281
2025
Q3
$940K Buy
7,400
+4,800
+185% +$571K ﹤0.01% 6432
2025
Q2
$319K Buy
+2,600
New +$297K ﹤0.01% 7746
2022
Q4
Sell
-24,200
Closed -$1.09M 9353
2022
Q3
$1.09M Sell
24,200
-19,921
-45% -$997K ﹤0.01% 5262
2022
Q2
$1.97M Sell
44,121
-22,123
-33% -$1.13M ﹤0.01% 4187
2022
Q1
$3.75M Sell
66,244
-28,408
-30% -$1.48M ﹤0.01% 3537
2021
Q4
$4.91M Buy
94,652
+68,883
+267% +$3.55M ﹤0.01% 2883
2021
Q3
$1.54M Buy
+25,769
New +$1.62M ﹤0.01% 5020
2020
Q3
Sell
-7,291
Closed -$359K 7291
2020
Q2
$359K Sell
7,291
-27,528
-79% -$1.49M ﹤0.01% 5569
2020
Q1
$1.77M Buy
+34,819
New +$2.01M ﹤0.01% 2145
2016
Q3
Sell
-20,992
Closed -$648K 4101
2016
Q2
$648K Buy
+20,992
New +$657K ﹤0.01% 2482

Other funds holding EHC

Jane Street's EHC Position: Q1 2026 in Review

Jane Street reduced its Encompass Health (EHC) stake by 98% in Q1 2026, selling an estimated $22.9M and leaving 4,260 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #8497.

Jane Street first reported a position in EHC in Q1 2017 and has held it in 34 quarters since. The position peaked at $29.6M in Q2 2025. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Jane Street held 4,260 shares of Encompass Health worth $412K as of Q1 2026.
  • Jane Street sold 222,938 Encompass Health shares in Q1 2026, an estimated $22.9M.
  • Encompass Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8497 holding.
  • Jane Street first reported a position in Encompass Health in Q1 2017 and has held it in 34 quarters since.
  • Jane Street's Encompass Health position peaked at $29.6M in Q2 2025.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.